Circulating cartilage oligomeric matrix protein in juvenile idiopathic arthritis

被引:10
作者
Lewander, P. [1 ,2 ]
Dahle, C. [1 ,3 ]
Larsson, B. [4 ]
Wettero, J. [1 ]
Skogh, T. [1 ,5 ]
机构
[1] Linkoping Univ, Div Neuro & Inflammat Sci, Dept Clin & Expt Med, Fac Med & Hlth Sci, SE-58183 Linkoping, Sweden
[2] Cty Council Ostergotland, Dept Paediat, Linkoping, Sweden
[3] Cty Council Ostergotland, Dept Clin Immunol & Transfus Med, Linkoping, Sweden
[4] Cty Council Ostergotland, Clin Chem Lab, Linkoping, Sweden
[5] Cty Council Ostergotland, Heart & Med Ctr, Rheumatol Clin, Linkoping, Sweden
关键词
RHEUMATOID-ARTHRITIS; GROWTH-FACTOR; JOINT DAMAGE; SERUM; COMP;
D O I
10.1080/03009742.2016.1192681
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: Raised serum cartilage oligomeric matrix protein (sCOMP) has been reported to predict erosive disease in early rheumatoid arthritis (RA). In juvenile idiopathic arthritis (JIA), subnormal sCOMP levels have been associated with ongoing inflammation and growth retardation. In this study we aimed to assess sCOMP, C-reactive protein (CRP), and insulin-like growth factor (IGF)-1 in children/adolescents with JIA and in referents.Method: We enrolled 52 JIA patients at planned outpatient visits and 54 inpatients with ongoing infection (infection referents'). A total of 120 referents testing negative for immunoglobulin (Ig)E-mediated allergy (IgE referents') served as controls. All serum samples were analysed for COMP, IGF-1, and CRP.Results: The average sCOMP level was highest among the IgE referents and lowest among the infection referents. In the JIA patients, the level of sCOMP was not associated with the level of CRP or with clinical signs of disease activity.Conclusions: The results of this study do not support routine clinical analysis of sCOMP levels in patients with JIA.
引用
收藏
页码:194 / 197
页数:4
相关论文
共 17 条
[1]   Outcome following onset of juvenile idiopathic inflammatory arthritis: I. Frequency of different outcomes [J].
Adib, N ;
Silman, A ;
Thomson, W .
RHEUMATOLOGY, 2005, 44 (08) :995-1001
[2]   Enhanced deposition of cartilage oligomeric matrix protein is a common feature in fibrotic skin pathologies [J].
Agarwal, Pallavi ;
Schulz, Jan-Niklas ;
Blumbach, Katrin ;
Andreasson, Kristofer ;
Heinegard, Dick ;
Paulsson, Mats ;
Mauch, Cornelia ;
Eming, Sabine A. ;
Eckes, Beate ;
Krieg, Thomas .
MATRIX BIOLOGY, 2013, 32 (06) :325-331
[3]   INSULIN-LIKE GROWTH-FACTOR AND GROWTH-HORMONE SECRETION IN JUVENILE CHRONIC ARTHRITIS [J].
ALLEN, RC ;
JIMENEZ, M ;
COWELL, CT .
ANNALS OF THE RHEUMATIC DISEASES, 1991, 50 (09) :602-606
[4]   Early increase in serum-COMP is associated with joint damage progression over the first five years in patients with rheumatoid arthritis [J].
Andersson, Maria L. E. ;
Svensson, Bjorn ;
Petersson, Ingemar F. ;
Hafstrom, Ingiald ;
Albertsson, Kristina ;
Forslind, Kristina ;
Heinegard, Dick ;
Saxne, Tore .
BMC MUSCULOSKELETAL DISORDERS, 2013, 14
[5]   Cartilage oligomeric matrix protein increases in serum after the start of growth hormone treatment in prepubertal children [J].
Bjarnason, R ;
Andersson, B ;
Kim, HS ;
Olsson, B ;
Swolin-Eide, D ;
Wickelgren, R ;
Kriström, B ;
Carlsson, B ;
Albertsson-Wikland, K ;
Carlsson, LMS .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (10) :5156-5160
[6]   Cartilage Oligomeric Matrix Protein in Patients with Juvenile Idiopathic Arthritis: Relation to Growth and Disease Activity [J].
Bjornhart, Birgitte ;
Juul, Anders ;
Nielsen, Susan ;
Zak, Marek ;
Svenningsen, Pernille ;
Muller, Klaus .
JOURNAL OF RHEUMATOLOGY, 2009, 36 (08) :1749-1754
[7]   Serum cartilage oligomeric matrix protein (COMP) decreases in rheumatoid arthritis patients treated with infliximab or etanercept [J].
Crnkic, M ;
Månsson, B ;
Larsson, L ;
Geborek, P ;
Heinegård, D ;
Saxne, T .
ARTHRITIS RESEARCH & THERAPY, 2003, 5 (04) :R181-R185
[8]   Diagnosis and classification of juvenile idiopathic arthritis [J].
Eisenstein, Eli M. ;
Berkun, Yackov .
JOURNAL OF AUTOIMMUNITY, 2014, 48-49 :31-33
[9]  
Gilliam BE, 2008, CLIN EXP RHEUMATOL, V26, P492
[10]   Interactions of the complement system with molecules of extracellular matrix: Relevance for joint diseases [J].
Happonen, Kaisa E. ;
Heinegard, Dick ;
Saxne, Tore ;
Blom, Anna M. .
IMMUNOBIOLOGY, 2012, 217 (11) :1088-1096